-
AstraZeneca denies the charge and says the allegation of ghostwriting is untrue.
FORBES
-
At the end of the day, the responsibility for the ghostwriting issue rests with the doctors and scientists that put their name on the by line (and cash the checks).
FORBES: Are Drug Industry Critics Trying To Bolster Their Own Image?
-
AstraZeneca's spokesperson says that while it does not support ghostwriting of papers, it does believe that it's proper for doctors to enlist medical writers to help them with their manuscripts.
FORBES: Pharma's Ghosts
-
To the extent that ghostwriting is a significant issue, the responsibility to address it lies with the docs and scientists who put their names on the by lines and the professional societies charged with their regulation.
FORBES: Are Drug Industry Critics Trying To Bolster Their Own Image?
-
Marcia Angell, a lecturer at Harvard University, former editor of The New England Journal of Medicine and author of The Truth About Drug Companies, wrote in an e-mail that ghostwriting practices are "evidently very common" in medicine.
FORBES: Pharma's Ghosts
-
She says ghostwriting practices are commonplace.
FORBES: Pharma's Ghosts
-
She wasn't somebody who could stand up and, say, like a Paul Robeson, make a whole sort of statement, but she could sing this song, and apparently, according to letters from--that I read of William Dufty, the ghostwriting journalist who wrote "The Lady Sings the Blues, " the FBI and other peoples actually said if she stopped singing this song they would give her an easier ride.
NPR: 'With Billie': A Jazz Great, As Others Saw Her